SUPPLIERS GUIDE Point-of-care testing
THE BIOMEDICAL SCIENTIST
15
POINT-OF-CARE TESTING Point-of-care testing has been one of the big stories of diagnostics recently. Here, we look at the latest developments.
A
number of research and market analysts have published reports on the projected growth of the point-of-care testing (POCT) sector over the next five years. Grand View Research said the global POCT market was valued at $18.09bn in 2018 and expects it to rise to $22.8bn by 2025. Its report states: “Continuous developments in research and development activities to miniaturise molecular and professional
P01-42 IBMS Suppliers Guide 2020_All Pages_v11gh.indd 15
diagnostic tests is anticipated to drive the demand for the devices. “In addition, improvements in lab automation techniques coupled with introduction of cost-effective and high-quality medical solutions is set to propel the growth.” Other analysts are even more optimistic about growth. For example, Global Market Insights expects the sector value to hit $36.6bn by 2025. It predicts a that the most growth will be in microfluids technology (9.2%), followed by
15/01/2020 11:36
